Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · IEX Real-Time Price · USD
1.960
-0.040 (-2.00%)
At close: May 20, 2024, 3:57 PM
1.990
+0.030 (1.53%)
After-hours: May 20, 2024, 7:55 PM EDT

Alterity Therapeutics Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Year 20232022202120202019 2018 - 2000
Selling, General & Admin
5.065.516.943.454.31
Upgrade
Research & Development
13.4815.1112.6410.4513.31
Upgrade
Other Operating Expenses
0.03000.040.13
Upgrade
Operating Expenses
18.5720.6319.5813.9417.75
Upgrade
Operating Income
-18.57-20.63-19.58-13.94-17.75
Upgrade
Other Expense / Income
-4.87-7.85-4.27-0.48-5.41
Upgrade
Pretax Income
-13.7-12.78-15.31-13.46-12.34
Upgrade
Income Tax
0.10.07000
Upgrade
Net Income
-13.81-12.85-15.31-13.46-12.34
Upgrade
Shares Outstanding (Basic)
2,4282,4061,697895616
Upgrade
Shares Outstanding (Diluted)
2,4282,4061,697895616
Upgrade
Shares Change
0.91%41.79%89.62%45.33%15.34%
Upgrade
EPS (Basic)
-3.42-3.18-5.40-9.00-12.00
Upgrade
EPS (Diluted)
-3.42-3.18-5.40-9.00-12.00
Upgrade
Free Cash Flow
-20.04-12.43-17.34-9.45-13.96
Upgrade
Free Cash Flow Per Share
-4.95-3.10-6.13-6.33-13.60
Upgrade
EBITDA
--12.78-15.31-13.46-12.34
Upgrade
EBIT
-13.7-12.78-15.31-13.46-12.34
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).